← Back to Screener
Allurion Technologies, Inc. Warrants, each whole warrant exercisable to purchase 0.056818 shares of common stock at an exercise price of $202.50 per share of common stock (ALUR.WS)
Price$0.00
Favorite Metrics
Price vs S&P 500 (26W)-75.70%
Price vs S&P 500 (4W)-38.45%
All Metrics
Price vs S&P 500 (YTD)-19.35%
10-Day Avg Trading Volume0.12M
3-Month Avg Trading Volume0.03M
52-Week High$0.07
26-Week Price Return-71.46%
13-Week Price Return-54.23%
3-Month Return Std Dev224.40%
Year-to-Date Return-22.22%
5-Day Price Return-25.63%
Month-to-Date Return-25.63%
Price vs S&P 500 (13W)-52.89%
52-Week Low$0.00
Industry Peers — Surgical & Medical Instruments(109)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
ALUR.WSAllurion Technologies, Inc. Warrants, each whole warrant exercisable to purchase 0.056818 shares of common stock at an exercise price of $202.50 per share of common stock | — | — | — | — | $0.00 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
About
Allurion Technologies develops a non-invasive obesity treatment platform centered on a swallowable intragastric balloon that requires no surgery, endoscopy, or anesthesia. The Allurion Program combines this proprietary balloon device with an AI-powered digital ecosystem that includes remote patient monitoring, behavioral coaching, secure messaging, and telehealth support. The company offers a procedure-less alternative to traditional bariatric interventions.